{"product_id":"tegens-160-mg-20-bustine-granulato-per-soluzione-orale","title":"Tegens 160 mg 20 sachets granules for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptoms attributable to venous insufficiency; states of capillary fragility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eTEGENS 160 mg hard capsules\u003c\/i\u003e: Each capsule contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: blueberry anthocyanoside complex with 36% anthocyanosides (Myrtocyan) 160 mg. \u003ci\u003eTEGENS 160 mg granules for oral solution\u003c\/i\u003e: Each sachet contains: \u003cu\u003eActive ingredient\u003c\/u\u003e: blueberry anthocyanoside complex with 36% anthocyanosides (Myrtocyan) 160 mg. \u003ci\u003eExcipient(s) with known effects\u003c\/i\u003e: one capsule contains 20 mg of lactose. One sachet contains 15 mg of lactose. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eHard capsules\u003c\/i\u003e: mannitol, \u003cb\u003elactose\u003c\/b\u003e, methylcellulose, citric acid, precipitated silica, magnesium stearate, gelatin (shell excipient). \u003ci\u003eGranules for oral solution\u003c\/i\u003e: mannitol, \u003cb\u003elactose monohydrate\u003c\/b\u003e, methylcellulose, anhydrous citric acid, blueberry aroma, ammonium glycyrrhizate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003ci\u003eADULTS\u003c\/i\u003e: capsules or sachets of granules: 1-2 per day. \u003cu\u003eIt is advisable to take this medicine in the morning and in the evening, with intervals of 12-24 hours\u003c\/u\u003e. Do not exceed the recommended doses. \u003cb\u003e \u003ci\u003ePediatric population\u003c\/i\u003e \u003c\/b\u003e The use of the product is reserved for adults. \u003cu\u003eMethod of administration\u003c\/u\u003e The granules, to be taken as such or dissolved in a little water, are recommended in subjects with swallowing difficulties and in conditions of irritability of the gastric mucosa due to gastric-ulcerative processes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eHard capsules\u003c\/i\u003e: Store at a temperature not exceeding 30°C. \u003ci\u003eGranules for oral solution\u003c\/i\u003e: no special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAs with all symptomatic treatments, it is necessary to contact your doctor if the symptoms do not improve after a short period of treatment. Clinical use has not highlighted the need for particular precautions when using the drug. This medicine contains lactose: patients suffering from rare hereditary problems of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medicine. \u003cb\u003e \u003ci\u003ePediatric population\u003c\/i\u003e \u003c\/b\u003e The use of the product is reserved for adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePhenomena attributable to interactions with other substances have never been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTEGENS has excellent tolerability. Rare cases of gastrointestinal disorders have been reported, such as heartburn, nausea and a sense of gastric heaviness, and skin rashes.\u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of overdose have been reported.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e The safety of the drug in pregnancy has not been determined, therefore it is advisable not to administer the product during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e During breastfeeding, the product should be used in cases of actual necessity under the direct supervision of the doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known negative effects on the ability to drive and use machines.\u003c\/p\u003e","brand":"Vemedia","offers":[{"title":"Default Title","offer_id":51730209931591,"sku":"023539075","price":15.3,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/vemedia-manufacturing-b-v-tegens-160-mg-20-bustine-granulato-per-soluzione-orale-farmacia-dottor-tili-1213791061.jpg?v=1767154667","url":"https:\/\/www.dottortili.com\/en-eu\/products\/tegens-160-mg-20-grantulation-pustine-for-oral-solution","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}